重大突发公共卫生事件背景下应急研发的新型举国体制研究:以新冠疫苗研发为例

Abstract
Figure/Table
References (0)
Related Citation (6)

Download: PDF (1197 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract The construction of the new national system under the conditions of the socialist market economy is one of the important contents of the construction of China's S&T and innovation governance system and even the national governance system in the new era.This paper focuses on the application scenarios of major public health emergencies, takes the new national system for the R&D in Emergency as the research object, and concentrates on answering questions about the necessity of adopting the new national system for the R&D in Emergency and the realization mechanism based on the case of China's COVID-19 vaccine R&D.The study found that the new national system, relying on institutional advantages, can meet the special needs of R&D in major public health emergencies, and has become an effective institutional arrangement for the R&D in Emergency.The study also found that in order to exert its institutional effectiveness, the new national system for the R&D in emergency must pay attention to the role of some key influencing factors, including the division of labor and cooperation between the government and the market, the connection between the R&D in emergency and the R&D in normal, the collaboration between the central and local governments, and the overall coordination of domestic and international resources, etc.The COVID-19 vaccine R&D is the successful application of the new national system for the R&D in Emergency of key technologies.The main realization mechanisms include leadership mechanism, organizational mechanism, technology tackling mechanism, technology reserve mechanism, central-local coordination mechanism and open innovation mechanism.

Key words： Major public health emergency R&D in emergency The new national system COVID-19 vaccine R&D

Received: 19 May 2022

PACS:

F061.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Fu Jinhua
	Cai Jinsong

Cite this article:

Fu Jinhua,Cai Jinsong. Research on the New National System forthe R&D in Emergency in the Context of Major Public Health Emergencies:Taking China's COVID-19 Vaccine R&D as an Example[J]. , 2023, 4(4): 168-177.

URL:

http://www.zgkjlt.org.cn/EN/ OR http://www.zgkjlt.org.cn/EN/Y2023/V4/I4/168

[1]谢宜泽,胡鞍钢.新型举国体制:时代背景、基本特征与适用领域[J].深圳大学学报 (人文社会科学版),2021,38 (4):18-26.
[2]陈劲,阳镇,朱子钦.新型举国体制的理论逻辑、落地模式与应用场景[J].改革,2021 (5):1-17.
[3]苏贵斌.新型举国体制:演进、特征与价值[J].西南石油大学学报 (社会科学版),2021,23 (3):53-59.
[4]黄寿峰.准确把握新型举国体制的六个本质特征[J].国家治理,2020 (11):7-10.
[5]唐亚林,郝文强.新型举国体制:历史演变、时代特征与模式构建[J].华东理工大学学报 (社会科学版),2021,36 (4):1-15.
[6]曹睿卓,董贵成.新型举国体制:概念、内涵与实现机制[J].科学社会主义,2021 (4):83-90.
[7]贾根良.构建以公共采购为支撑的 “网络型举国体制”[J].国家治理,2020 (11):41-44.
[8]梁华.新型举国体制在抗击疫情中的优势展现[J].理论探索,2021 (5):90-95.
[9]鲍明晓.关于建立和完善新型举国体制的理论思考[J].天津体育学院学报,2001,16 (4):48-51.
[10]珂言.构建新型举国体制的几个关系[J].体育文化导刊,2002 (3):6-7.
[11]何虎生.内涵、优势、意义:论新型举国体制的三个维度[J].人民论坛,2019 (11):56-59.
[12]刘戒骄,方莹莹,王文娜.科技创新新型举国体制:实践逻辑与关键要义[J].北京工业大学学报 (社会科学版),2021,21 (5):89-101.
[13]陈劲,阳镇,朱子钦. “十四五”时期 “卡脖子”技术的破解:识别框架、战略转向与突破路径[J].改革,2020 (12):5-15.
[14]方炜,唐路路,孙泽华,等.新型举国体制下大飞机产业科技创新动力机制研究[J].中国科技论坛,2021 (7):57-65.
[15]蔡跃洲.中国共产党领导的科技创新治理及其数字化转型:数据驱动的新型举国体制构建完善视角[J].管理世界,2021 (8):30-45.
[16]张于喆,张铭慎,郑腾飞.构建新型科技创新举国体制若干思考[J].开放导报,2021 (6):36-47.
[17]王皓田.深化科技体制改革要注重发挥 “新型举国体制”的制度优势[J].中国经贸导刊,2020 (12):19-22.
[18]黄瑶,王铭.新型举国体制对防控新冠疫情的制度优势[J].理论探讨,2021 (2):167-172.
[19]申晓勇,武力.我国在新型举国体制视角下重大疫情的应对[J].经济导刊,2020 (4):12-18.
[20]钟秉枢.新型举国体制:体育强国建设之保障[J].上海体育学院学报,2021,45 (3):1-7.
[21]林盼.新型举国体制如何落地:打造以国企为主导的创新平台[J].华东理工大学学报 (社会科学版),2021,36 (4):26-35.
[22]LURIE N,MANOLIO T,PATTERSON A P,et al.Research as a part of public health emergency response[J].New England journal of medicine,2013,368 (13):1251-1255.
[23]薛澜.科学在公共决策中的作用:聚焦公共卫生事件中的风险研判机制[J].科学学研究,2020,38 (3):385-387.
[24]马佳,李天柱,银路.新冠疫情背景下应急研发的快速应答机制研究[J].科学学与科学技术管理,2021,42 (4):49-69.
[25]王欣,王九云.基于有效性的科技参与应对重大突发事件的原则与目标[J].管理世界,2014 (6):182-183.
[26]宋英华.应急管理科技创新体系构建研究[J].科学学与科学技术管理,2009,30 (4):87-90.
[27]钟书华.国家应急科技支撑体系框架构想[J].中国科技论坛,2004 (5):32-35.
[28]马佳,李天柱,银路.新冠疫情背景下应急研发的组织模式[J].中国科技论坛,2021 (7):37-45.
[29]王超,张伟然,许海云,等.突发公共卫生危机中科研应急力量的协同整合研究:以诊断试剂应急研发为例[J].情报理论与实践,2021,44 (1):138-146.
[30]惠娟,谭清美.重大突发公共卫生事件科技研发应急体系运行机制研究[J].科技进步与对策,2020,37 (9):11-20.
[31]江宏飞,高建平,周伟.公共卫生事件下中医药应急科研体系的构建:基于中医药应对新冠疫情的案例分析[J].科研管理,2020,41 (9):160-169.
[32]温志强.风险社会中突发事件的特征与处置理念探析[J].防灾技术高等专科学校学报,2005,7 (4):12-16.
[33]HAFFAJEE R,PARMET W E,MELLO M M.What is a public health emergency[J].New England journal of medicine,2014,371 (11):986-988.
[34]武汉大学国家发展战略研究院新冠病毒疫情防控研究课题组.抗击新冠病毒疫情的中国经验[J].学习与实践,2020 (4):22-34.
[35]孟莎,张永宏,陶明玲,等.从突发公共卫生事件的防控看科研管理应急机制的建立:以传染病专科医院为例[J].北京医学,2011,33 (6):510-511.
[36]崔洁,张衡,李穗怀,等.广东省应急管理科技支撑的现状与对策研究[J].科技管理研究,2016 (4):81-85.
[37]张海波,童星.中国应急管理结构变化及其理论概化[J].中国社会科学,2015 (3):58-84.
[38]胡颖廉.举国协同:新型举国体制的制度解释:以新冠疫苗研发为例[J].中共中央党校 (国家行政学院)学报,2021,25 (6):84-91.